Private Equity

BlackRock has once again boosted its holding in Finnish drugmaker Orion to over 5%. We decode what this calculated move signals for Orion's future.

Shirl Penney's CEO of the Year award signals a major shift. Discover how his model of 'Supported Independence' empowers advisors and reshapes finance.

Anthem Properties' new rental towers signal a major investment trend. But can this 'build and hold' strategy truly address Vancouver's housing crisis?

Hedge fund Balyasny Asset Management reveals a major stake in the Unite-Empiric takeover, signaling a high-stakes arbitrage play amid regulatory scrutiny.

A landmark government scheme is injecting billions into innovation. Can venture capitalists like Beyond Ventures turn this capital into a tech and health boom?

Lexicon's sotagliflozin may revolutionize HFpEF treatment by targeting adipose tissue, a move that could differentiate it in a crowded market.

A key regulatory filing reveals growing investor confidence in the American Axle-Dowlais deal, a move poised to reshape the global automotive supply chain.

A PE firm's operational overhaul of a corporate carve-out leads to a strategic sale, highlighting the consolidation and tech trends reshaping security.

Henri Beaufour’s passing transfers a major Ipsen stake to a charity. We analyze the governance safeguards and what it means when philanthropy enters the boardroom.

Galderma secured stringent EU approval to use its Sculptra biostimulator on the body, targeting a billion-dollar market and setting a new industry benchmark.

In a crowded market, one Vietnamese hotel is using maximalist Italian art to redefine ultra-luxury. A deep dive into a bold business differentiation strategy.

A monumental $31.5 billion contract tasks Peraton with replacing the FAA's aging air traffic control system. Can it succeed where others have failed?

TELUS just secured $2.3 billion in a complex debt offering. We decode the move and what it signals about its high-tech ambitions beyond telecom.

With a high-grade Alaskan asset secured and a $44M war chest, Vizsla Copper is making a bold move in the race for North American resource security.

Baxter is buying back billions in debt, a strategic move to clean its balance sheet. But with operational issues mounting, is it enough to win back investors?

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

With $15M in new funding and seasoned mining execs on board, Getty Copper is now debt-free and poised to unlock the potential of its vast copper assets.

A new Texas BBQ joint opens in Airdrie, but it's more than a meal. It’s a story of strategic growth, local entrepreneurship, and building community.

A class action lawsuit against Telix Pharmaceuticals reveals the perilous gap between optimistic corporate disclosures and harsh regulatory setbacks.

Westinghouse's new robotics deal with PROMATION is more than a partnership; it’s a key move in building a Canadian supply chain for a global nuclear revival.